Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

A Phase 1 First-in-Human Study of Abbv-383, a BCMA × CD3 Bispecific T-Cell-Redirecting Antibody, As Monotherapy in Patients with Relapsed/Refractory Multiple Myeloma

Blood (2022) 140 (Supplement 1): 4401–4404.

https://doi.org/10.1182/blood-2022-167008

Published: 2022

Journal Articles

Use of FLAG+Venetoclax As Consolidation/Bridge to HSCT in Patients with Acute Myeloid Leukemia

Aneesha Ananthula, Dharmini Manogna, Sree Lanka, Katharine Thomas, Hana Safah, Nakhle S. Saba, Francisco Socola

Blood (2022) 140 (Supplement 1): 11734–11735.

https://doi.org/10.1182/blood-2022-168272

Published: 2022

Journal Articles

COVID-19 Immune Response in Hematologic Malignancies: Analysis of COVID-19 Anti-Spike Antibodies in Previously Infected and Uninfected Patients

Alex Niu, Victor H Ramirez, Bronwyn Gunn, Melyssa Bratton, Sarah Foster, James Robinson, Sree Lanka, Hana Safah, Francisco Socola, Yunwen Huang, Crystal Y Zheng, Ivy V Trinh, Amelie E Murrell, Jeffrey G Shaffer, Elizabeth B Norton, Nakhle S. Saba

Blood (2022) 140 (Supplement 1): 8351–8353.

https://doi.org/10.1182/blood-2022-165019

Published: 2022

Journal Articles

COVID-19 Convalescent Plasma Decreased Oxygen Requirement and Hospital Stay in COVID-19 Hospitalized Patients Including Those with Hematological Malignancies: A Report of 16 Patients

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-141578

Published: 2020

Journal Articles

COVID-19 in Patients with Hematological Malignancies: High False Negative Rate with High Mortality

Alex Niu, MD, Bo Ning, PhD, Francisco Socola, MD, Hana Safah, MD, Tim Reynolds, Moayed Ibrahim, MD, Firas Safa, MD, Tina Alfonso, Alfred Luk, MD, David M Mushatt, MD, Tony Hu, PhD, Nakhle S. Saba, MD

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-138611

Published: 2020

Journal Articles

Gastrointestinal Events and Management Strategies for Patients with Acute Myeloid Leukemia (AML) in First Remission Receiving CC-486 in the Randomized, Placebo-Controlled, Phase III QUAZAR AML-001 Maintenance Trial

Farhad Ravandi, MBBS, Christopher Pocock, MBBS, Dominik Selleslag, MD, Pau Montesinos, MD PhD, Hamid Sayar, MD MSc, Maurizio Musso, MD, Angela Figuera Alvarez, Hana Safah, MD, William Tse, MD FACP, Sang Kyun Sohn, MDPhD, Devendra K Hiwase, MBBS, MD FRACP, FRCPA, PhD, Timothy Chevassut, Francesca Pierdomenico, Ignazia La Torre, Barry Skikne, MD, Keshava Kumar, PhD, Qian Dong, DrPH, C.L. Beach, PharmD, Hervé Dombret, MD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-137669

Published: 2020

Journal Articles

Reduction in Transplantation Activity without Impairment in Outcomes in the Covid-19 Era- Data from the Sarah Cannon Blood Cancer Network (SCBCN)

Minoo Battiwalla, MD, Carlos Bachier, MD, Vikas Bhushan, MD, Michael J. Eckrich, MD MPH, Alireza Eghtedar, MD, Haydar Frangoul, MD, Suman Kambhampati, MD, Shahbaz Malik, MD, Peter A. McSweeney, MD, Jeremy Pantin, MBBS, Aravind Ramakrishnan, MD, Hana Safah, MD, Paul J Shaughnessy, MD, Betsy Blunk, BSN, RN, BMTCN, Tonya Cox, BSN, RN, Rocky Billups, MS, Charles F. Lemaistre, MD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-139121

Published: 2020

Journal Articles

The Paracaspase MALT1 Acts Independently of Pre-B-Cell Receptor Signaling As a Key Factor in Leukemic Cell Survival in Precursor B-Cell Acute Lymphoblastic Leukemia

Nakhle S. Saba, MD, Jade Meyers, Lorena Fontan, PhD, Ari Melnick, MD, Adrian Wiestner, MD PhD, Patricia Lobelle-Rich, Ekaterina Kim, MS, Jan A. Burger, MD PhD, Yara Mouawad, MD, Prescott L. Deininger, PhD, Francisco Socola, MD, Hana Safah, MD, Erik K Flemington, PhD

Blood (2019) 134 (Supplement_1): 1288.

https://doi.org/10.1182/blood-2019-131376

Published: 2019

Journal Articles

Central Nervous System Prophylaxis Is Required and Associated with a Prolonged Overall Survival in Both Early and Advanced-Stage Primary Adrenal/Renal Diffuse Large B-Cell Lymphoma

John Xie, MD, Motohide Uemura, MD PhD, Shigeaki Nakazawa, MD PhD, Teresa Calimeri, MD PhD, Andres JM Ferreri, MD, Francisco Socola, MD, Hana Safah, MD, Nakhle S. Saba, MD

Blood (2019) 134 (Supplement_1): 2908.

https://doi.org/10.1182/blood-2019-129158

Published: 2019

Journal Articles

Tetraploidy in Acute Myeloid Leukemia Is Associated with Poor Outcomes Regardless of the Presence of Favorable Risk Features, and Requires an Allogeneic Stem Cell Transplant in First Remission

Bachir Berbari, MD, Matthew E. Behrens, Lindsey J. Hathaway, MD, Bachir Farah, MD, Ali Baghian, MD, Georges E. Tanios, MD, Theresa C. Brown, PhD, John J. Schmieg, MD PhD, Hana Safah, MD, Nakhle S. Saba, MD

Blood (2017) 130 (Supplement 1): 1308.

https://doi.org/10.1182/blood.V130.Suppl_1.1308.1308

Published: 2017

Journal Articles

CD5-Negative Mantle Cell Lymphoma Defines a Distinct Disease Entity Characterized By an Indolent Clinical Course Irrespective of Known Prognostic Markers

Arshia Soleimani, MD, John J. Schmieg, MD PhD, Theresa C. Brown, PhD, Lei Yin, MS Candidate, Hana Safah, MD, Nakhle S. Saba, MD

Blood (2017) 130 (Supplement 1): 4061.

https://doi.org/10.1182/blood.V130.Suppl_1.4061.4061

Published: 2017

Journal Articles

Primary Dural Diffuse Large B-Cell Lymphoma Is Associated with Good Prognosis and Is Effectively Treated with CHOP-R Alone

Zachary L. Quinn, MD, Karam Zakharia, MD, Lei Yin, MS Candidate, Theresa C. Brown, PhD, John J. Schmieg, MD PhD, Hana Safah, MD, Nakhle S. Saba, MD

Blood (2017) 130 (Supplement 1): 4166.

https://doi.org/10.1182/blood.V130.Suppl_1.4166.4166

Published: 2017

Journal Articles

Targeting MALT1 with the Small Molecule Inhibitor MI2 Induces a Caspase-Dependent Apoptosis and Inhibits the NF-κb Pathway in Chronic Lymphocytic Leukemia Primary Cells

Georges Tanios, MD, Patricia Lobelle-Rich, Ashwin Vasudevamurthy, MD, Thomas S. Atkinson, MD, Ali Baghian, MD, Delong Liu, PhD, Hana Safah, MD, Erik K. Flemington, PhD, Nakhle S. Saba, MD

Blood (2016) 128 (22): 1597.

https://doi.org/10.1182/blood.V128.22.1597.1597

Published: 2016

Journal Articles

A Systemic Review of CD5-Negative Mantle Cell Lymphoma Identifies Potential Clinical and Biological Implications

Arshia Soleimani, MD, Georges Tanios, MD, Hana Safah, MD, Nakhle S. Saba, MD

Blood (2016) 128 (22): 3048.

https://doi.org/10.1182/blood.V128.22.3048.3048

Published: 2016

Journal Articles

A Prospective Randomized Double Blind Phase 3 Clinical Trial of Anti- T Lymphocyte Globulin (ATLG) to Assess Impact on Chronic Graft-Versus-Host Disease (cGVHD) Free Survival in Patients Undergoing HLA Matched Unrelated Myeloablative Hematopoietic Cell Transplantation (HCT)

Blood (2016) 128 (22): 505.

https://doi.org/10.1182/blood.V128.22.505.505

Published: 2016

Journal Articles

Long-Term Outcomes of Autologous Hematopoietic Cell Transplantation Using Melphalan and Total Body Irradiation Conditioning in Multiple Myeloma

Ali Baghian, MD, Reinhold Munker, MD, Yordanka Koleva, MPH, Gunita Matharoo, MPH, Patricia Andrews, MPH, Ato Wright, MD PhD, Nakhle S. Saba, MD, Hana Safah, MD

Blood (2016) 128 (22): 4644.

https://doi.org/10.1182/blood.V128.22.4644.4644

Published: 2016

Journal Articles

A myeloproliferative neoplasm with translocation t(8;9)(p22;p24) involving JAK2 gene

Nakhle Saba, Hana Safah

Blood (2013) 122 (6): 861.

https://doi.org/10.1182/blood-2013-03-487348

Published: 2013

Journal Articles

Immunotransplantation for Hematologic Malignancies Using Allogeneic Peripheral Blood Stem Cell Transplantation.

Sujal Shah, MD, Edgardo S. Santos, M.D., John Rink, P.A.-C, Todd Roberts, M.D., Hana Safah, M.D.

Blood (2007) 110 (11): 5060.

https://doi.org/10.1182/blood.V110.11.5060.5060

Published: 2007

NARROW

A Phase 1 First-in-Human Study of Abbv-383, a BCMA × CD3 Bispecific T-Cell-Redirecting Antibody, As Monotherapy in Patients with Relapsed/Refractory Multiple Myeloma

Use of FLAG+Venetoclax As Consolidation/Bridge to HSCT in Patients with Acute Myeloid Leukemia

COVID-19 Immune Response in Hematologic Malignancies: Analysis of COVID-19 Anti-Spike Antibodies in Previously Infected and Uninfected Patients

COVID-19 Convalescent Plasma Decreased Oxygen Requirement and Hospital Stay in COVID-19 Hospitalized Patients Including Those with Hematological Malignancies: A Report of 16 Patients

COVID-19 in Patients with Hematological Malignancies: High False Negative Rate with High Mortality

Gastrointestinal Events and Management Strategies for Patients with Acute Myeloid Leukemia (AML) in First Remission Receiving CC-486 in the Randomized, Placebo-Controlled, Phase III QUAZAR AML-001 Maintenance Trial

Reduction in Transplantation Activity without Impairment in Outcomes in the Covid-19 Era- Data from the Sarah Cannon Blood Cancer Network (SCBCN)

The Paracaspase MALT1 Acts Independently of Pre-B-Cell Receptor Signaling As a Key Factor in Leukemic Cell Survival in Precursor B-Cell Acute Lymphoblastic Leukemia

Central Nervous System Prophylaxis Is Required and Associated with a Prolonged Overall Survival in Both Early and Advanced-Stage Primary Adrenal/Renal Diffuse Large B-Cell Lymphoma

Tetraploidy in Acute Myeloid Leukemia Is Associated with Poor Outcomes Regardless of the Presence of Favorable Risk Features, and Requires an Allogeneic Stem Cell Transplant in First Remission

CD5-Negative Mantle Cell Lymphoma Defines a Distinct Disease Entity Characterized By an Indolent Clinical Course Irrespective of Known Prognostic Markers

Primary Dural Diffuse Large B-Cell Lymphoma Is Associated with Good Prognosis and Is Effectively Treated with CHOP-R Alone

Targeting MALT1 with the Small Molecule Inhibitor MI2 Induces a Caspase-Dependent Apoptosis and Inhibits the NF-κb Pathway in Chronic Lymphocytic Leukemia Primary Cells

A Systemic Review of CD5-Negative Mantle Cell Lymphoma Identifies Potential Clinical and Biological Implications

A Prospective Randomized Double Blind Phase 3 Clinical Trial of Anti- T Lymphocyte Globulin (ATLG) to Assess Impact on Chronic Graft-Versus-Host Disease (cGVHD) Free Survival in Patients Undergoing HLA Matched Unrelated Myeloablative Hematopoietic Cell Transplantation (HCT)

Long-Term Outcomes of Autologous Hematopoietic Cell Transplantation Using Melphalan and Total Body Irradiation Conditioning in Multiple Myeloma

A myeloproliferative neoplasm with translocation t(8;9)(p22;p24) involving JAK2 gene

Immunotransplantation for Hematologic Malignancies Using Allogeneic Peripheral Blood Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only